FIL Ltd - Feb 2, 2023 Form 3 Insider Report for Structure Therapeutics Inc. (GPCR)

Role
Other*, 10%+ Owner
Signature
Stephanie J. Brown, Duly authorized under Powers of Attorney, by and on behalf of FIL Limited, Eight Roads Shareholdings Limited, and its direct and indirect subsidiaries, Eight Roads Holdings Limited and Eight Roads Investments
Stock symbol
GPCR
Transactions as of
Feb 2, 2023
Transactions value $
$0
Form type
3
Date filed
2/2/2023, 05:30 PM
Previous filing
Oct 28, 2021
Next filing
Feb 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GPCR Series A Convertible Preferred Shares Feb 2, 2023 Ordinary Shares 4.01M Eight Roads Investments F1
holding GPCR Series A+ Convertible Preferred Shares Feb 2, 2023 Ordinary Shares 620K Eight Roads Investments F1
holding GPCR Series B Convertible Preferred Shares Feb 2, 2023 Ordinary Shares 453K Eight Roads Investments F1
holding GPCR Series B-1 Convertible Preferred Shares Feb 2, 2023 Ordinary Shares 179K Eight Roads Investments F1
holding GPCR Series A Convertible Preferred Shares Feb 2, 2023 Ordinary Shares 71.6K ERVC Healthcare Advisors IV, LP F1
holding GPCR Seriers A+ Convertible Preferred Shares Feb 2, 2023 Ordinary Shares 10.2K ERVC Healthcare Advisors IV, LP F1
holding GPCR Series B Convertible Preferred Shares Feb 2, 2023 Ordinary Shares 7.41K ERVC Healthcare Advisors IV, LP F1
holding GPCR Series B-1 Convertible Preferred Shares Feb 2, 2023 Ordinary Shares 494K ERVC Healthcare V, LP F1
holding GPCR Series A Convertible Preferred Shares Feb 2, 2023 Ordinary Shares 624K ERVC Healthcare IV, LP F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Series A+, A, B, and B-1 preferred shares are convertible on a 1-for-1 basis into the number of shares of Ordinary Shares as shown in column 3 at any time at the holder's election, and automatically upon the closing of the Issuer's initial public offering without payment or further consideration, and have no expiration date.

Remarks:

Remark 1:Eight Roads Shareholdings Limited ("ERSL") and Pandanus Partners, LP ("Pandanus") own shares of Eight Roads Holdings Limited ("ERHL") voting stock. ERHL is the immediate parent company of Eight Roads Investments ("ERI"), which owns the shares being reported on with this Form. While the percentage of total voting power represented by ERSL's and Pandanus' shares of ERHL voting stock may fluctuate due to changes in the total number of shares of ERHL voting stock outstanding from time to time, ERSL's holdings represents more than 50% and Pandanus' holding represents more than 25% and less than 50% of, the total votes which may be cast by all holders of ERHL voting stock. The shares in ERSL are owned primarily by officers and senior employees of FIL Limited and Eight Roads together with several charitable organizations. No such person or organization owns or controls more than 25% of the voting stock in ERSL. Pandanus Associates, Inc. ("PAI") acts as general partner of Pandanus. Pandanus is owned by trusts for the benefit of members of the Johnson family, including ERHL's Chairman Abigail P. Johnson, but disclaims that any such member is a beneficial owner of the securities reported on this form. The address of ERSL, ERHL and ERI is 42 Crow Lane, Hamilton HM19, Bermuda. The address of Pandanus is c/o FIL Limited, 42 Crow Lane, Hamilton HM19, Bermuda. The address of PAI is 11 Keewaydin Drive, Suite 100, Salem, NH, USA, 03079. ERVC Healthcare IV, LP and ERVC Healthcare V, LP (Collectively "ERVC HC") are limited partners. The General Partners of ERVC HC are ERVC Healthcare Advisors V, LP and ERVC Healthcare Advisors IV, LP (collectively "ERVC HCA"). The general partner of ERVC HCA is Eight Roads GP, which is controlled by ERSL. Remark 2: The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the undersigned are the beneficial owners of any securities reported herein.